Main Article Content

Abstract

Purpose: This study aimed to analyze the treatment of dengue hemorrhagic fever in adult inpatients at Panti Rahayu Yakkum Purwodadi Hospital and to evaluate the appropriateness of therapy based on the 2020 Indonesian Ministry of Health guideline.
Research Method: This research used a non-experimental observational design with a retrospective descriptive-analytic approach. Data were collected from the medical records of 95 adult inpatients diagnosed with dengue hemorrhagic fever during January-September 2025 using purposive sampling. The variables included patient characteristics, supportive therapy, concomitant drugs, and therapeutic appropriateness. Data were analyzed descriptively and evaluatively.
Results and Discussion: The most frequently used therapies were Ringer Lactate infusion (96.84%), paracetamol 500 mg (50.53%), and intravenous paracetamol (45.26%). Evaluation showed appropriate indication in 70.5% of cases, appropriate drug in 51.6%, appropriate patient in 93.7%, and appropriate dose in 95.8%. The findings indicate that dengue treatment was largely dominated by supportive therapy, although some inappropriate drug use was still identified.
Implications: The findings underscore the importance of adherence to clinical guidelines for improving therapeutic safety and effectiveness. Further studies are recommended to examine the relationship between therapeutic appropriateness, clinical outcomes, complications, and length of hospitalization.

Keywords

dengue hemorrhagic fever adult inpatients supportive therapy therapeutic appropriateness hospital treatment clinical guideline

Article Details

How to Cite
Widodo, M. M. V. ., Setyowati, E., & Ulviani Yulia Husna. (2026). Analysis of Dengue Hemorrhagic Fever in Adult Patients in Panti Rahayu Yakkum Purwodadi Hospital. Advances in Healthcare Research, 4(1). https://doi.org/10.60079/ahr.v4i1.706

References

  1. Agustin, A. C., Nugroho, Y. E., Pangesti, I., Studie, P., Applied, S., Laboratory, T., Science, F. F., Cilacap, U. A., Cilacap, U. A., Cilacap, U. A., & Tengah, C. J. (2023). The Relationship Between Platelet and Leukocyte Counts In Adult Patients With Dengue Hemorrhagic Fever ( DHF ) To. Scientific Journal of Pharmacy, 6(2), 41–45.
  2. Andriani, N., Tjitrosantoso, H., & Yamlean, P. (2024). A Study on the Management of Dengue Hemorrhagic Fever (DHF) Treatment Therapy in Children Undergoing Treatment at Prof. Dr. R.D Kandou Hospital in 2013. Scientific Journal of Pharmacy, 3(2), 57–61.
  3. Aziza, N. (2023). Research methodology 1: quantitative descriptive. ResearchGate, July, 166–178.
  4. Azzahra and Narsa. (2023). Analysis of Characteristics and Treatment Profiles of Pediatric Dengue Patients in the Inpatient Installation of Samarinda Medika Citra Hospital in 2020-2021. Journal of Science and Health, 5(1), 10–18. https://doi.org/10.30872/rqszt256
  5. Color, M. P. (2023). Dengue: Update on Clinically Relevant Therapeutic Strategies and Vaccines. Current Treatment Options in Infectious Diseases, 27–52. https://doi.org/10.1007/s40506-023-00263-w
  6. Evolution et al., (2025). Infection, Genetics and Evolution. ScienceDirect, 127, 1–14.
  7. Evolution, G., Evolution, G., Etiology, V. D., & Overview, P. (2025). Infection, Genetics and Evolution. ScienceDirect, 127, 1–14.
  8. Faridah, Dania, Chen, Supadmi, Purwanto, Heriyanto, Aufa, Chang, & Perwitasari. (2022). Dynamic Changes of Platelet and Factors Related Dengue Haemorrhagic Fever : A Retrospective Study in Indonesian. 1–12.
  9. Guo, Gu, Zhang, Zhang, Weng, & Wu. (2025). Platelet dynamics and thrombocytopenia in dengue fever : A prospective cohort study from Shenzhen , China. New Microbes and New Infections, 67(August), 101624. https://doi.org/10.1016/j.nmni.2025.101624
  10. Hartini, I. S., Prasetyo, E. Y., Kusumaratni, D. A., Pratama, Y., & Prodyanatasari, A. (2024). Hospital Environment Rational Use of Analgesics and Antipyretic Drugs in Patients With Dengue Hemorrhagic Fever in a Hospital. 148–157.
  11. Ichsan, F., Torry, G., & Bhega, G. (2024). Dengue Hemorrhagic Fever Treatment Pattern in the Inpatient Installation at St. Gabriel Kewapante Hospital. Journal of Health and Pharmaceutical Sciences, 1(1), 15–20. https://jurnal1.akfarstfransiskusxaverius.ac.id/index.php/jikf/article/view/6
  12. Jimat, Ismawatie, Maulina, & Rahmawati. (2025). Dengue at Rsu Pku Muhammadiyah Delanggu. 6(September), 13748–13754.
  13. Kusumawardani, Mulyowati, & Binugraheni. (2022). Proceeding 2 nd SETIABUDI – CIHAMS 2022 The Relationship Between Aedes Aegypti Larval Density and the Incidence of Dengue Infection in Sukoharjo R.
  14. Lombardia, D. B. (2025). Machine Translated by Google Travel Medicine and Infectious Diseases Dengue fever outbreak in 2023 in Lombardy , Italy : A single health perspective Machine Translated by Google. ScienceDirect, 64, 1–9.
  15. Madanayake, Jayawardena, Wijekoon, & Perera. (2021). Fluid requirement in adult dengue haemorrhagic fever patients during the critical phase of the illness : an observational study. That is why we need to be vigilant, and we need to be vigilant.
  16. Meriska, Nisa, Susanti, Ressi, & Nurmainah. (2019). Evaluation of the Management of Dengue Hemorrhagic Fever (DHF) Therapy in Pediatric Patients at the Inpatient Installation of Sultan Syarif Mohamad Alkadrie Hospital in 2019. Far Journal.
  17. Ministry of Health, RI (2020). Guidelines for the Management of Adult Dengue Fever. Book.
  18. Nugraheni, E., Rizqoh, D., & Sundari, M. (2023). Clinical Manifestations of Dengue Hemorrhagic Fever (DHF). Journal of Medicine and Health: Scientific Publications of the Faculty of Medicine, Sriwijaya University, 10(3),267–274. https://doi.org/10.32539/jkk.v10i3.21425
  19. RI, K. E. P. and P. K. N. K. K. (2021). National Health Research and Development Ethical Guidelines and Standards.
  20. Rosyida, R. (2023). Journal of Maneksi vol 12, no. 3, September 2023. 12(3), 656–666.
  21. Sanjaya, D. A., Meriyani, H., Siada, B., Elvenia, M., Damayanti, A., Pharmacy, F., Denpasar, M., Study, P., Pharmacy, S., Denpasar, U. M., Sciences, H., Jaya, A., & Cochran, U. (2025). Evaluation of Therapy for Dengue Hemorrhagic Fever Patients at Bali Provincial General Hospital. Journal of P, 10(1), 1–17.
  22. Suganthi, Shanmugam, Pendian, & Nithya. (2023). Seroprevalence of dengue virus infection by detection of NS1 antigen. 9(July 2021), 53–56.
  23. Sukoharjanti, Sabaan, Setyowati, Isnaini, & Anggraini. (2023). Effect of Dosing Melinjo Leaf Ethanol Extract ( G Netum G Nemon L .) T is facing a nityretic m encit p utih. 8(1), 1– 6.
  24. Sutriyawan, A., & Suherdin, S. (2022). Mixed Method Study: Epidemiological Overview and Analysis of Dengue Hemorrhagic Fever (DHF) Surveillance System in the City of Bandung. The Indonesian Journal of Infectious Diseases, 8(2), 15–29. https://doi.org/10.32667/ijid.v8i2.144
  25. Syumarta, Y. (2014). Research Article on the Relationship between Platelet Count, Hematocrit and Hemoglobin with Dengue Hemorrhagic Fever Clinical Degree in Patients. Andalas Health Journal, 3(3), 492–498.
  26. Tayal, A., Kumar, S., & Rakesh, K. (2023). Machine Translated by Google Dengue Hemorrhagic Fever Management : A Recent Review of Machine Translated by Google. 90(February), 168–177.
  27. World Health Organization. (2024). Dengue. https://www-who-int.translate.goog/news-room/fact-sheets/detail/dengue-and-severe dengue?_x_tr_sl=en&_x_tr_tl=id&_x_tr_hl=id&_x_tr_pto=tc